Healthcare Sales & Marketing Network News: Ascend

Searching News Database: Ascend

HSMN NewsFeed - 1 Jun 2026
Veritas Aortic Solutions, an inQB8 Spinout, Raises $12M to Advance Non-Surgical Treatment of Aortic Root and Ascending Aortic Diseases
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 17 Mar 2025
Latigo Biotherapeutics Closes $150 Million in Series B Financing to Advance Non-Opioid Pain Therapeutics
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 23 Dec 2024
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Biopharmaceuticals

HSMN NewsFeed - 3 Apr 2024
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 11 Mar 2024
PulseCath Achieves MDR CE Certification for iVAC 2L, Paving the Way for Complex High-Risk Percutaneous Coronary Interventions
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 20 Feb 2024
Avidity Biosciences Receives FDA Rare Pediatric Disease Designation for AOC 1044 for Treatment of Duchenne Muscular Dystrophy in People with Mutations Amenable to Exon 44 Skipping
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Jan 2024
Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline
Biopharmaceuticals Neurology Venture Capital

HSMN NewsFeed - 20 Jan 2023
Astellas Announces Hold Lifted by FDA on FORTIS Clinical Trial of AT845 Investigational Treatment for Adult Patients with Late-Onset Pompe Disease
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Dec 2022
STORM Therapeutics announces closing of USD $30M Series B financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 Aug 2022
Inhibikase Therapeutics Announces FDA Clearance of Investigational New Drug Application for IkT-001Pro for the Treatment of Chronic Myelogenous Leukemia
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 15 Aug 2022
Alternative Pathway Blocker Anti-Bb Antibody (NM8074) Receives US FDA Clearance to Start Efficacy Trial in C3 Glomerulopathy (C3G) Patients
Biopharmaceuticals FDA

HSMN NewsFeed - 3 Mar 2022
Inhibrx Receives FDA Orphan-Drug Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency
Biopharmaceuticals FDA

HSMN NewsFeed - 17 May 2021
Soteria Biotherapeutics Launches with $42 Million Series A Financing Led by Roche Venture Fund and 5AM Ventures
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 28 Apr 2021
Roam Robotics Announces Ascend Smart Knee, Pioneering a New Era of Human Mobility
Devices Orthopaedic Product Launch

HSMN NewsFeed - 9 Mar 2021
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib)
Diagnostics Oncology FDA

HSMN NewsFeed - 1 Mar 2021
Vascular Graft Solutions Wins FDA approval to Market the VIOLA(TM) Clampless Proximal Anastomosis System for CABG
Devices Cardiology Surgery FDA

HSMN NewsFeed - 28 Jan 2021
Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate
Biopharmaceuticals Licensing

HSMN NewsFeed - 9 Nov 2020
Prometheus Biosciences Announces $130 Million Financing to Advance Precision Medicines for the Treatment of Inflammatory Bowel Disease
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 9 Sep 2020
Lilly Announces Leadership Changes
Biopharmaceuticals Personnel

HSMN NewsFeed - 21 Jul 2020
Data from Lilly at Alzheimer's Association International Conference 2020(R) (AAIC 2020) to Showcase Clinical Advances in Alzheimer's Research
Biopharmaceuticals Neurology

HSMN NewsFeed - 15 Jul 2020
Edwards' KONECT RESILIA Aortic Valved Conduit Receives FDA Approval For Complex Aortic Valve Surgeries
Devices Cardiology Surgery FDA

HSMN NewsFeed - 26 May 2020
Sierra Oncology Appoints Dr. Stephen Dilly as President and Chief Executive Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 7 Nov 2019
EIP Pharma Announces U.S. FDA Grants Fast-Track Designation to Neflamapimod as a Treatment for Dementia with Lewy Bodies (DLB)
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 10 Sep 2019
Pharvaris Announces $66 Million Series B Financing to Advance the Clinical Development of an Oral Therapy for Hereditary Angioedema
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 6 Jun 2019
Palatin Technologies Granted FDA Orphan Drug Designation -- PL-8177 for the Treatment of Non-Infectious Uveitis
Biopharmaceuticals Ophthalmology FDA

HSMN NewsFeed - 16 Jan 2019
Therachon is Granted Orphan Drug Designation by US FDA for Apraglutide for the Treatment of Short Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 26 Dec 2018
Venus Medtech Completes Merger with Keystone Heart, Ltd.
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 25 Sep 2018
Venus Medtech Announces Agreement to Acquire Keystone Heart, LTD
Devices Interventional Mergers & Acquisitions

HSMN NewsFeed - 29 Aug 2018
Impel NeuroPharma Annouces First Subject Dosed In Phase 1 Trial Evaluating INP105 For The Treatment Of Acute Agitation In Bipolar I Disorder And Schizophrenia
Biopharmaceuticals Drug Delivery Neurology

HSMN NewsFeed - 21 Aug 2018
Audentes Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by the FDA to AT132 for the Treatment of X-Linked Myotubular Myopathy
Biopharmaceuticals Regenerative Medicine FDA

HSMN NewsFeed - 6 Aug 2018
CureGenetics raises $17 million in Series A Financing
Biopharmaceuticals Diagnostics Personnel

HSMN NewsFeed - 21 Jun 2018
Alimera Sciences Appoints Mary T. Szela to its Board of Directors
Biopharmaceuticals Ophthalmology Personnel

HSMN NewsFeed - 5 Jun 2018
Audentes Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to AT132 for the treatment of X-Linked Myotubular Myopathy
Biopharmaceuticals Regulatory

HSMN NewsFeed - 7 May 2018
Salix Receives FDA Approval For PLENVU(R), Next Generation 1-Liter Bowel Cleansing Preparation For Colonoscopies
Biopharmaceuticals Radiology Gastroenterology FDA

HSMN NewsFeed - 20 Apr 2018
SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer & Treasurer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 12 Feb 2018
Ferring's CLENPIQ(TM) (sodium picosulfate, magnesium oxide, and anhydrous citric acid) Oral Solution for Colonoscopy Prep Now Available
Biopharmaceuticals Gastroenterology Product Launch

HSMN NewsFeed - 9 Feb 2018
Salix Provides Update on FDA Submission for PLENVU(R)
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 2 Aug 2017
Eloxx Pharmaceuticals Secures US$8 Million Investment from LSP, Increasing Total Raised in Series C to US$38 Million
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 8 Jun 2017
SciClone Enters Into Definitive Merger Agreement To Be Acquired By Consortium Led By GL Capital
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 9 Feb 2017
Syndax Appoints Richard P. Shea as Chief Financial Officer
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Dec 2016
Stavros G. Vizirgianakis Appointed President and CEO of Misonix, Inc.
Devices Surgery Personnel

HSMN NewsFeed - 7 Dec 2016
Panther Biotechnology Receives Positive Feedback from the FDA
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Nov 2016
The Medicines Company Discontinues Development of MDCO-216, its Investigational Cholesterol Efflux Promoter
Biopharmaceuticals Cardiology

HSMN NewsFeed - 29 Aug 2016
Elite Announces Development and License Agreement with SunGen Pharma LLC
Biopharmaceuticals Generics Licensing

HSMN NewsFeed - 9 May 2016
Elite Pharmaceuticals to Present SequestOx(TM) Data at the American Pain Society 35th Annual Scientific Meeting
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 4 May 2016
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 14 Apr 2016
Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 12 Apr 2016
Elite Pharmaceuticals Announces Changes to their Board of Directors
Biopharmaceuticals Personnel

HSMN NewsFeed - 17 Mar 2016
Elite Announces U.S. FDA Priority Review Designation for SequestOx(TM) NDA
Biopharmaceuticals FDA

HSMN NewsFeed - 29 Jan 2016
Helix BioPharma Corp. Announces Appointment of New Directors to the Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 19 Jan 2016
Allakos Successfully Completes Dosing in Phase 1 Clinical Trial of AK001 and Announces Expansion of its Executive Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 13 Jan 2016
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Nov 2015
Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 29 Sep 2015
Audentes Therapeutics Expands Senior Leadership Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Sep 2015
Merck and Pfizer Announce FDA Orphan Drug Designation for Investigational Immunotherapy Avelumab in Merkel Cell Carcinoma
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 8 Sep 2015
Selecta Announces $38 Million Series E Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 15 May 2015
Cortendo AB: Cortendo Adds Two Late-Stage Assets to Its Rare Endocrine Disease Franchise and Announces Related $33.2 Million Financing
Biopharmaceuticals Acquisitions Licensing Venture Capital

HSMN NewsFeed - 23 Feb 2015
Eiger BioPharmaceuticals Announces Presentation of Positive Data in Patients Infected with Hepatitis Delta Virus (HDV) Treated with Lonafarnib
Biopharmaceuticals

HSMN NewsFeed - 18 Feb 2015
aTyr Pharma Receives EMA Orphan Drug Designation for Resolaris(TM) in FSHD
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Dec 2014
Ascendis Pharma A/S Completes $60 million Oversubscribed Series D Financing
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 27 Oct 2014
Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's EstroGel(R)
Biopharmaceuticals Distribution

HSMN NewsFeed - 24 Oct 2014
Elite Pharmaceuticals Announces New Management Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Aug 2014
Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market
Biopharmaceuticals Distribution

HSMN NewsFeed - 17 Jun 2014
Edwards Lifesciences Launching SAPIEN XT Valve In The U.S.
Devices Interventional Cardiology Product Launch

HSMN NewsFeed - 28 Apr 2014
Sanovas Expands Management Team
Devices Personnel

HSMN NewsFeed - 7 Apr 2014
Alios BioPharma Raises $41 Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 20 Mar 2014
William R. Ringo Joins Mirati Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 6 Mar 2014
Immune Design Appoints William Ringo to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
Biopharmaceuticals

HSMN NewsFeed - 20 Nov 2013
MAQUET Cardiovascular Announces Study Results Demonstrating HEARTSTRING(R) Device Associated with Significant Reduction in Coronary Artery Bypass Stroke Risk
Devices Surgery Cardiology

HSMN NewsFeed - 13 Nov 2013
Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial of Plecanatide in Patients with Chronic Idiopathic Constipation
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 8 Nov 2013
Sorin Group Announces First European Implant of Mitroflow Valsalva Conduit
Devices Cardiology

HSMN NewsFeed - 4 Nov 2013
A.P. Pharma Makes Key Management Appointments
Biopharmaceuticals Drug Delivery Personnel

HSMN NewsFeed - 8 Oct 2013
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products
Biopharmaceuticals Generics Licensing

HSMN NewsFeed - 19 Sep 2013
Arrowhead Promotes David Lewis to Chief Scientific Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Aug 2013
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 5 Aug 2013
Elite Pharmaceuticals, Inc. Appoints Nasrat Hakim asElite Pharmaceuticals, Inc. Appoints Nasrat Hakim as President and Chief Executive Officer President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 18 Jun 2013
Sunshine Heart's C-Pulse Device Reaches Treatment Milestone for Heart Failure
Devices Cardiology

HSMN NewsFeed - 6 Feb 2013
SpinalCyte, LLC Reports the Addition of Jeffrey Geesin, Ph.D. to Clinical Advisory Board
Devices Regenerative Medicine Personnel

HSMN NewsFeed - 6 Feb 2013
Elite Pharmaceuticals Announces FDA Approval of Supplemental Application for Naltrexone
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 15 Jan 2013
Versartis Closes $25 Million Series C Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 28 Nov 2012
Arena Pharmaceuticals and Ildong Pharmaceutical Enter Into Co-Development and License Agreement for Temanogrel, a Novel Agent for Thrombotic Diseases
Biopharmaceuticals Licensing Cardiology

HSMN NewsFeed - 13 Nov 2012
Boston Therapeutics Names Jonathan B.Rome Chief Operating Officer
Biopharmaceuticals Endocrinology Personnel

HSMN NewsFeed - 6 Nov 2012
Sorin Group Announces U.S. Launch of New Heart Device for Simultaneous Implantation of an Aortic Tissue Valve and Ascending Aorta
Devices Cardiology

HSMN NewsFeed - 18 Sep 2012
Sarepta Therapeutics' Lead Therapeutic Drugs for Ebola and Marburg Viruses Receive FDA Fast Track Designation
Biopharmaceuticals FDA

HSMN NewsFeed - 31 Aug 2012
Sophiris' Drug for Benign Prostatic Hyperplasia was Well Tolerated Using the Preferred Transrectal Route of Administration
Biopharmaceuticals Urology

HSMN NewsFeed - 13 Aug 2012
Teva Receives FDA Acceptance of Its New Drug Application for Quartette(TM) (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for the Prevention of Pregnancy
Biopharmaceuticals FDA

HSMN NewsFeed - 12 Jul 2012
Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 May 2012
RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 May 2012
ACT Announces Massachusetts Eye and Ear as Additional Site for Clinical Trial for Dry Age-Related Macular Degeneration Using Human Embryonic Stem Cell-Derived RPE Cells
Regenerative Medicine Ophthalmology

HSMN NewsFeed - 19 Apr 2012
Carestream Health Receives FDA Clearance for New DRX-Revolution Mobile X-Ray System
Devices Radiology FDA

HSMN NewsFeed - 2 Apr 2012
Aerocrine: The ACAAI & AAAAI issue a joint position statement in support of the American Thoracic Society (ATS) Guidelines on FeNO
Devices

HSMN NewsFeed - 23 Mar 2012
Ascendx Spine(TM) Appoints Eric W. Gilbert as Vice President of Sales & Marketing for its U.S. Operations
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 23 Feb 2012
Ascendx Spine(TM) elects Magnus Persson, MD, PhD, to its board of directors
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 21 Dec 2011
Impax Pharmaceuticals Submits New Drug Application for IPX066 in Parkinson’s Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 29 Nov 2011
Ascendx Spine(TM) Appoints Pilar Debelius-Kinsey as Sales and Marketing Manager, Europe
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 12 Sep 2011
InterMune Announces Launch of Esbriet(R) (pirfenidone) in Germany
Biopharmaceuticals

HSMN NewsFeed - 15 Aug 2011
Pulmatrix Invests in Clinical Programs in COPD and Cystic Fibrosis
Biopharmaceuticals

HSMN NewsFeed - 30 Jun 2011
Sheila Gujrathi, M.D. Named Chief Medical Officer of Receptos
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Mar 2011
Edwards Lifesciences Expands Treatable Patient Population With European Approval of Larger Transcatheter Valve
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 24 Feb 2011
Edwards Lifesciences Expands Treatable Patient Population With European Approval of Larger Transcatheter Valve
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 21 Jan 2011
On-X LTI Receives FDA Approval for Aortic Valve with Vascutek Graft
Devices Cardiology FDA

HSMN NewsFeed - 7 Jan 2011
JPB Capital Partners and Ilex Consumer Products Group Acquire ST. JOSEPH'S(R) ASPIRIN Brand From Johnson & Johnson
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 16 Dec 2010
GlaxoSmithKline and Impax Pharmaceuticals Enter Global Agreement to Develop and Commercialize a late stage compound for Parkinson’s Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Sep 2010
Sunshine Heart(R) to Develop Smaller Next Generation Controller for Its C-Pulse(R) Heart Assist System
Devices Cardiology

HSMN NewsFeed - 31 Aug 2010
Sunshine Heart Announces First Minimally Invasive Thoracotomy Procedures Performed for the C-Pulse(R) Heart Assist System
Devices Cardiology

HSMN NewsFeed - 10 Aug 2010
Atrium Announces Two New Surgical Mesh Contracts with Premier
Devices Surgery Group Purchasing

HSMN NewsFeed - 5 Aug 2010
First Patient Treated with Medtronic's Valiant(R) Thoracic Stent Graft in Aortic Dissection Trial
Devices Interventional Cardiology

HSMN NewsFeed - 27 Apr 2010
MAQUET Cardiovascular Announces Study Results Showing Significantly Reduced Stroke Rate In Coronary Artery Bypass Patients When Aortic Clamping is Avoided
Devices Cardiology Surgery

HSMN NewsFeed - 2 Mar 2010
Edwards SAPIEN XT Transcatheter Valve and Delivery Systems Receive CE Mark
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 3 Feb 2010
Sanomedics Names Jordan Serlin Chief Operating Officer
Devices Personnel

HSMN NewsFeed - 26 Jan 2010
Edwards Lifesciences Initiates Clinical Study of Minimally Invasive Aortic Valve Surgery System
Devices Cardiology Surgery

HSMN NewsFeed - 5 Jan 2010
Corcept Therapeutics Announces Four Anticipated Milestones for 2010
Biopharmaceuticals

HSMN NewsFeed - 2 Dec 2009
Elite Pharmaceutics and ThePharmaNetwork Announce FDA Approval for Generic Methadone Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 8 Sep 2009
First Human Cases Performed With Edwards Lifesciences' New Transapical Heart Valve System
Devices Cardiology

HSMN NewsFeed - 24 Aug 2009
ProFibrix Raises US $11 Million (EUR 8 million) in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Jul 2009
Benjamin L. Palleiko Named Chief Financial Officer of Ore Pharmaceuticals
Biopharmaceuticals Personnel

HSMN NewsFeed - 29 May 2009
New Preliminary Data from Two Studies Show Clinical Activity of Neratinib in Combination with Trastuzumab and in Combination with Paclitaxel in Advanced HER-2 Positive Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 May 2009
Edwards Lifesciences Reports Positive Data From Its Largest Transcatheter Valve Implant Series
Devices Interventional Cardiology

HSMN NewsFeed - 14 May 2009
Edwards Lifesciences Announces First Human Implants With 18 French Transcatheter Valve System
Devices Interventional Cardiology

HSMN NewsFeed - 11 Mar 2009
Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
Devices Interventional Cardiology

HSMN NewsFeed - 5 Mar 2009
NeuroMetrix to Reorganize US Sales Operations
Devices Personnel

HSMN NewsFeed - 17 Feb 2009
Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
Biopharmaceuticals Drug Delivery

HSMN NewsFeed - 27 Oct 2008
New Study Shows ENBREL(R) (etanercept) Is More Effective than a DMARD in the Treatment of Symptoms of Ankylosing Spondylitis Patients
Biopharmaceuticals

HSMN NewsFeed - 16 Jul 2008
Peptimmune Announces the Second Close of Series D Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 17 Jun 2008
Elan and Wyeth Announce Encouraging Top-line Results from Phase 2 Clinical Trial of Bapineuzumab for Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 3 Jun 2008
Lexicon's Drug Candidate for Carcinoid Syndrome Receives Fast Track Status From the FDA
Biopharmaceuticals

HSMN NewsFeed - 2 Jun 2008
Abiomed Receives 510(k) Clearance from FDA for Impella 2.5 Device
Devices Cardiology FDA

HSMN NewsFeed - 5 Mar 2008
Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
Devices Interventional Cardiology

HSMN NewsFeed - 5 Mar 2008
PanGenetics Raises 23 Million Euro in Series C Financing to Fund Clinical Advancement of Its Therapeutic Antibody Programs
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 29 Jan 2008
Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
Devices Interventional Cardiology FDA

HSMN NewsFeed - 17 Jan 2008
Peptimmune Announces First Close of Series D Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Jan 2008
Medical Simulation Corporation and Edwards Lifesciences Launch Edwards SAPIEN Transcatheter Heart Valve Training Program in Europe
Devices Cardiology

HSMN NewsFeed - 27 Dec 2007
Endo Pharmaceuticals to Develop and Commercialize Alexza's AZ-003 Staccato(R) Inhaled Fentanyl Product
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 5 Dec 2007
Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 4 Dec 2007
Myriad Genetics Submits IND on Vivecon
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 3 Dec 2007
Texas Heart Institute at St. Luke's Episcopal Hospital Participates in Ground-Breaking Heart Recovery Technology Study
Devices Cardiology

HSMN NewsFeed - 28 Nov 2007
Synthetic Blood Announces VCURES Receives $1.3 Million From U.S. Navy for Decompression Sickness Research with Oxycyte
Biopharmaceuticals

HSMN NewsFeed - 26 Nov 2007
Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
Biopharmaceuticals HIV/AIDS

HSMN NewsFeed - 12 Nov 2007
Lexicon Files Investigational New Drug Application for LX2931 as a Potential Treatment for Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Oct 2007
Significant New Data on Roche's PEGASYS(R) and Hepatitis C Pipeline Compounds to be Featured at 58th Annual AASLD Meeting
Biopharmaceuticals

HSMN NewsFeed - 24 Oct 2007
R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Oct 2007
Positron Introduces New Attrius(TM) Cardiac PET Scanner at the Annual Meeting of the American Society of Nuclear Cardiology
Devices Radiology Cardiology

HSMN NewsFeed - 15 Oct 2007
New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 15 Oct 2007
Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb
Biopharmaceuticals Licensing

HSMN NewsFeed - 1 Oct 2007
Valeant Pharmaceuticals to Partner with ASCEND Therapeutics to Promote Migranal(R) to OB/GYNs
Biopharmaceuticals

HSMN NewsFeed - 27 Sep 2007
Columbia Laboratories Signs U.S. License and Supply Agreement with Ascend Therapeutics to Market PROCHIEVE(R) 4% Progesterone Gel
Biopharmaceuticals Licensing

HSMN NewsFeed - 26 Sep 2007
EnVivo Pharmaceuticals Announces Executive Appointment
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Sep 2007
Shareholders Approve Inhibitex Acquisition of FermaVir
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Sep 2007
Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
Devices Cardiology Regulatory

HSMN NewsFeed - 2 Sep 2007
New Data On Orexin Receptor Antagonist Almorexant Shows Therapeutic Potential to Restore Normal Physiological Sleep in Patients Suffering From Insomnia
Biopharmaceuticals

HSMN NewsFeed - 18 Jul 2007
Abiomed Announces Canadian Regulatory Approvals of Impella Circulatory Support Technologies
Devices Interventional Cardiology Regulatory

HSMN NewsFeed - 17 Jul 2007
Secondary Endpoints of Phase II/III Study Confirm Clear Benefits from Treatment With removab(R) for Patients with Malignant Ascites
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Jun 2007
Scios Announces Enrollment of First Patients in ASCEND-HF Trial in Acute Heart Failure
Biopharmaceuticals Cardiology

HSMN NewsFeed - 21 May 2007
Elan and Wyeth to Initiate Phase 3 Clinical Trial of Bapineuzumab (AAB-001) in Alzheimer's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 May 2007
Neurogen Announces Results of First-in-Human Trial for New Approach to Treating Obesity
Biopharmaceuticals

HSMN NewsFeed - 19 Apr 2007
Abiomed Announces Australian Regulatory Approval of Impella Circulatory Support Technologies
Devices Cardiology Regulatory

HSMN NewsFeed - 10 Apr 2007
CoMentis Initiates Phase II Clinical Trial for AMD Eye Drop Therapy
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 28 Mar 2007
Abiomed Announces Data on Impella 2.5 for Improved Cardiac Function for Pre-Shock Acute Myocardial Infarction
Devices Cardiology

HSMN NewsFeed - 20 Mar 2007
Edwards Lifesciences Receives U.S. Approval for Landmark Transcatheter Heart Valve Pivotal Trial
Devices Interventional Cardiology

HSMN NewsFeed - 20 Mar 2007
InterMune Updates Expense Forecasts and Development Plans
Biopharmaceuticals

HSMN NewsFeed - 7 Mar 2007
First Thoracic Patient Successfully Treated with Endologix's Powerlink Dissection Stent System
Devices Interventional

HSMN NewsFeed - 15 Feb 2007
ThermoGenesis Corp. Names Cell Therapy Device Sales Expert Daniel A. Segal as Vice President of Sales & Marketing
Devices Personnel

HSMN NewsFeed - 5 Feb 2007
Successful Proof-of-Concept With Actelion's Orexin Receptor Antagonist in Patients Suffering From Primary Insomnia -- First Demonstration of Key Role of Orexin System in Humans Suffering From Sleep Disorders
Biopharmaceuticals

HSMN NewsFeed - 5 Dec 2006
Edwards Lifesciences Reorganizes Operations
Devices Cardiology

HSMN NewsFeed - 1 Dec 2006
Treatment of Ulcerative Colitis With Asacol Improved Patient Quality of Life in as Early as Three Weeks, According to New Data Analysis
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 13 Nov 2006
Scios Announces Selection of Independent Executive Committee and Planned Protocol Design for the ASCEND-HF Landmark International Outcomes Trial of NATRECOR(R) (nesiritide)
Biopharmaceuticals Cardiology

HSMN NewsFeed - 18 Jul 2006
HistoRx Names John Tonkinson, Ph.D., Vice President, Business Development
Diagnostics Personnel

HSMN NewsFeed - 13 Jul 2006
CoGenesys Receives FDA Clearance to Commence Clinical Trials of Cardeva in Patients with Chronic Heart Failure
Biopharmaceuticals Cardiology FDA

Return to NewsFeed

Additional items found! 72

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 72 additional stories matching:
Ascend
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!